Skip to content 
- NURS 6501 Week 8 Assignment Case Study Analysis
Student name
Walden University
NURS 6501
Professor Name
Submission Date
Case Study Analysis
In this case study, the patient is a 52-year-old male who had acute left great toe discomfort. The patient cannot touch his foot with a sheet as the level of pain is 10/10. The patient is on HCTZ 12.5 mg and Simvastatin 20 mg daily because of hypertension and high levels of cholesterol. His other vital signs indicate that he has a slightly high temperature. In the meantime, there is first metatarsophalangeal joint erythema and oedema that are detected by physical examination. Uric acid and ESR diagnoses are high with normal X-rays.
Musculoskeletal Pathophysiologic Processes
The pain and swelling of the metatarsophalangeal joint of this patient and the development of erythema and oedema during the initial few hours of the disease presented are a clear indication of gout. Therefore, the acute and chronic inflammation of gout is caused by monosodium urate crystals that are deposited in joints and soft tissues. Immunopathogenesis: Hyperuricemia or high blood uric acid.
The uric acid of this patient is 10mg/dl, which is significantly higher than the normal level (3.5-7.2mg/dl in men), which favours gout. The urate crystals in the joint space inflame the joint space through the activation of the NLRP3 inflammasome that produces pro-inflammatory cytokines like IL-10. These cytokines attract neutrophils and other inflammatory cells to the site, resulting in erythema, swelling, and excruciating pain. Post-party business-related symptoms can suggest a trigger (e.g., purine-enriched foods (e.g., red meat, shellfish) or alcohol that can elevate the level of uric acid and trigger gout exacerbations). Thiazide diuretics (HCTZ) can also induce hyperuricemia as they suppress renal uric acid secretion.
Racial/Ethnic Variables Impacting Physiological Functioning
Because of the racial and ethnic differences in genetic, dietary, and lifestyle factors, the prevalence and clinical manifestations of gout across races and ethnic groups differ. Studies show that Pacific Islanders, Māori, and African Americans experience more gout than Caucasians (Alghubayshi et al., 2022). In these populations, hyperuricemia and gout are genetically determined by polymorphisms in genes of urate transport and metabolism (e.g., SLC2A9, ABCG2). The racial/ethnic background of this patient can influence his risk of gout. As an illustration, the patient belongs to a hyperuricemia-prone genetic community, so this could be a contributor to his illness. Culturally influenced dietary habits can influence the level of uric acid and exacerbation of gout.
Pathophysiologic Processes Affecting the Patient
Acute gout in this patient is caused by the complex of hyperuricemia, dietary triggers, and pharmaceutical use. The renal uric acid excretion diminishes owing to chronic treatment of hypertension with HCTZ, elevating the levels of blood urate. Simvastatin, a drug used to control excessive cholesterol, has no impact on uric acid levels but unveils the presence of metabolic risk factors in the patient. The urate crystal-induced joint inflammation exacerbates clinical symptoms (Cabáu et al., 2019).
The fact that the ESR (32 mm/hr) is elevated suggests systemic inflammation, which is equivalent to acute joint inflammation. Normal X-rays are exhibited by early gout, which does not have any joint erosion or long-term changes, indicating the acute nature of the condition. The fact that the patient has a slightly increased temperature could be the manifestation of the systemic inflammatory response, yet there is no infection, as there are no additional symptoms, his breathing is normal, and his oxygen level is normal.
Conclusion
Conclusively, hyperuricemia, dietary intake, and medications were identified as causes of the development of severe pain in the first metatarsophalangeal joint of gout in this particular case study. In combination with his hypertension medication, clinical and characteristic features of the patient, including elevated uric acid and inflammatory markers, indicate gout.
The physiological functioning that is ethnically specific may assist the patients to understand their inclination to gout and hence devise appropriate management strategies. Gout flares with hyperuricemia, acute inflammation, and other factors can be prevented by patient education and dietary change that eliminates the use of alcohol and Augusta and other NSAIDs.
References
Alghubayshi, A., Edelman, A., Alrajeh, K., & Roman, Y. (2022). Genetic assessment of hyperuricemia and gout in Asian, Native Hawaiian, and Pacific Islander subgroups of pregnant women: biospecimens repository cross-sectional study. BMC Rheumatology, 6(1). https://doi.org/10.1186/s41927-021-00239-7
Cabău, G., Crișan, T. O., Klück, V., Popp, R. A., & Joosten, L. A. B. (2019). Immunological Reviews, 294(1), 92–105. https://doi.org/10.1111/imr.12833
K Manjuladevi, Ravindran, K., & P. Rahini. (2019). A review of gouty arthritis. Research Journal of Pharmacy and Technology, 12(11), 5583–5583. https://doi.org/10.5958/0974-360x.2019.00967.3
Raja, R., Kavita, F., Amreek, F., Shah, A., Sayeed, K. A., & Sehar, A. (2019). Hyperuricemia associated with thiazide diuretics in hypertensive adults. Cureus, 11(8). https://doi.org/10.7759/cureus.5457
